Deep Dive 19 minutes PremiumHead-to-Head in US Drugstore Retailing: CVS Health vs. Walgreens Boots Alliance Aditya Kaushik, Analyst Sector Lead: Swarooprani Muralidhar, Director of Research and Managing Director of Healthcare March 20, 2023 Table of ContentsIntroduction Market Scale and Opportunity CVS Health vs. Walgreens Boots Alliance: Coresight Research Analysis 1. Overview 2. Revenue 3. Operating Profit and Margins 4. Key Strategies 5. Customer Purchases 6. Store Metrics 6. Technological Advancements 7. Supply Chain Strategies 8. Recent Acquisition Activities What We Think Implications for Retailers What's InsideCVS Health and Walgreens Boots Alliance are the top retailers in the US drugstore sector, offering a wide variety of medicines and other products. As part of the Coresight Research Head-to-Head series, we provide analysis of the companies’ revenues, financial performances, customer purchase trends, store metrics, technological advancements and key strategies. Data in this report include: Revenue, broken down by segment, for CVS Health and Walgreens Boots Alliance for fiscal 2017–2022 Operating profits and margins for both companies for fiscal 2017–2022 Proprietary Coresight Research data on retailers drugstore or pharmacy visitors purchased from in early 2023 Store numbers for CVS and Walgreens for fiscal 2017–2022 Monthly US store traffic for both companies for December 2021–December 2022 Companies mentioned in this report include: CVS Health, Microsoft, Signify Health, Summit Health and Walgreens Boots Alliance Other relevant research: Market Outlook: US Drugstores—Focusing on Tech-Enabled Healthcare Solutions Walmart To Expand Its Health Footprint, Plans To Nearly Double Its Healthcare Centers by 2025 US CPG—Consumer Health: Understanding a Category Marked by Spin-Offs All Coresight Research of the drugstore sector This report is for Premium subscribers only. Learn more about subscriptions here.If you are a Premium subscriber, please log in. Other research you may be interested in:
